Loading stock data…
LUCY
$1.03-0.02 (-1.79%)
Market ClosedLast close May 1
Lucyd, Inc engages in the development and sale of smart eyeglasses and sunglasses in North America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Lucyd, Inc in the Healthcare sector is trading at $1.03. The stock is currently near its 52-week low of $0.95, remaining 32.6% below its 200-day moving average. Technical signals show neutral RSI of 35 and bearish MACD signal, explaining why LUCY maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 35) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.03
Potential Upside
5%
Whystock Fair Value$1.08
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Lucyd, Inc engages in the development and sale of smart eyeglasses and sunglasses in North America. Its flagship product is the Lucyd Lyte which enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perfor...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.62M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-83.73%
Volume
Today's trading volume
22,624
Recent News
Tariffs Put Businesses in Crisis. Waiting for the Refund Could Be Worse.
Getting their money back is going to be a slow, messy fight, and some business owners are running out of time. Others are mounting a fight.
Top Midday Gainers
Monte Rosa Therapeutics (GLUE) said Wednesday early trial results of its drug candidate, MRT-8102, s
BC-Most Active Stocks
HIVE Digital Technologies Ltd. 18,030,962 3.2599
Innovative Eyewear Second Quarter 2025 Earnings: US$0.66 loss per share (vs US$1.87 loss in 2Q 2024)
NasdaqCM:LUCY 1 Year Share Price vs Fair Value Explore Innovative Eyewear's Fair Values from the Community and select...
Innovative Eyewear First Quarter 2025 Earnings: US$0.72 loss per share (vs US$3.04 loss in 1Q 2024)
Innovative Eyewear ( NASDAQ:LUCY ) First Quarter 2025 Results Key Financial Results Revenue: US$454.5k (up 19% from 1Q...